Literature DB >> 10802503

Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.

G V Stajich1, G P Lopez, S W Harry, W R Sexson.   

Abstract

Thimerosal, a derivative of mercury, is used as a preservative in hepatitis B vaccines. We measured total mercury levels before and after the administration of this vaccine in 15 preterm and 5 term infants. Comparison of pre- and post-vaccination mercury levels showed a significant increase in both preterm and term infants after vaccination. Additionally, post-vaccination mercury levels were significantly higher in preterm infants as compared with term infants. Because mercury is known to be a potential neurotoxin to infants, further study of its pharmacodynamics is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802503     DOI: 10.1067/mpd.2000.105133

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Vaccination safety update.

Authors:  Burkhard Schneeweiss; Michael Pfleiderer; Brigitte Keller-Stanislawski
Journal:  Dtsch Arztebl Int       Date:  2008-08-25       Impact factor: 5.594

2.  Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines.

Authors:  Michael E Pichichero; Angela Gentile; Norberto Giglio; Margarita Martin Alonso; Maria Veronica Fernandez Mentaberri; Grazyna Zareba; Thomas Clarkson; Carlos Gotelli; Mariano Gotelli; Lihan Yan; John Treanor
Journal:  J Pediatr       Date:  2009-06-26       Impact factor: 4.406

3.  Parenteral nutrition as an unexpected and preventable source of mercury exposure in preterm infants.

Authors:  Karola Jering; Michael Aschner; Amy Beller; Ellyn L Hamm; Margaret Langdon; Nathalie L Maitre
Journal:  J Pediatr       Date:  2015-03-24       Impact factor: 4.406

4.  Author reply: To PMID 24235069.

Authors:  Yan-Ni Chen; Jue Wang
Journal:  World J Pediatr       Date:  2014-05       Impact factor: 2.764

Review 5.  Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.

Authors:  Mark Bigham; Ray Copes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Abating Mercury Exposure in Young Children Should Include Thimerosal-Free Vaccines.

Authors:  José G Dórea
Journal:  Neurochem Res       Date:  2017-04-24       Impact factor: 3.996

7.  Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

Authors:  Mieszko Olczak; Michalina Duszczyk; Pawel Mierzejewski; Teresa Bobrowicz; Maria Dorota Majewska
Journal:  Neurochem Res       Date:  2010-08-28       Impact factor: 3.996

Review 8.  Are neuropathological conditions relevant to ethylmercury exposure?

Authors:  Michael Aschner; Sandra Ceccatelli
Journal:  Neurotox Res       Date:  2009-09-16       Impact factor: 3.911

9.  Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.

Authors:  Rejane C Marques; José G Dórea; Márlon F Fonseca; Wanderley R Bastos; Olaf Malm
Journal:  Eur J Pediatr       Date:  2007-01-20       Impact factor: 3.860

10.  B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal.

Authors:  Martyn A Sharpe; Taylor L Gist; David S Baskin
Journal:  J Toxicol       Date:  2013-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.